Filtros de búsqueda

Lista de obras de Xavier Montalban

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

scientific article published on 07 April 2020

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells

artículo científico publicado en 2020

A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis

artículo científico publicado en 2011

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.

artículo científico publicado en 2010

A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.

artículo científico publicado en 2015

A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease

artículo científico publicado en 2003

A longitudinal study of cognition in primary progressive multiple sclerosis

artículo científico publicado en 2005

A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'.

artículo científico publicado en 2014

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis

scientific article published on 21 June 2019

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.

artículo científico

A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.

artículo científico publicado en 2015

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.

artículo científico publicado en 2011

A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis

scientific article published on 10 July 2020

A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.

artículo científico publicado en 2009

A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.

artículo científico publicado en 2009

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

artículo científico publicado en 2009

A three-year, multi-parametric MRI study in patients at presentation with CIS

artículo científico publicado en 2008

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis

artículo científico publicado en 2009

A validation study of manual atrophy measures in patients with Multiple Sclerosis

artículo científico publicado en 2020

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.

artículo científico publicado en 2009

ANKRD55 and DHCR7 are novel multiple sclerosis risk loci

article

ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.

artículo científico publicado en 2015

Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study

Activation-induced cell death in T lymphocytes from multiple sclerosis patients

artículo científico publicado en 2014

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

artículo científico publicado en 2020

Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study

artículo científico publicado en 2019

Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.

artículo científico publicado en 2001

Altered maturation of circulating dendritic cells in primary progressive MS patients

scientific article published on 15 May 2006

Amelioration of flulike symptoms at the onset of interferon β- 1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction

artículo científico publicado en 1998

An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.

artículo científico publicado en 2011

An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.

artículo científico publicado en 2016

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients

artículo científico publicado en 2016

Analysis of prognostic factors associated with longitudinally extensive transverse myelitis.

artículo científico publicado en 2012

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

artículo científico publicado en 2012

Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors.

artículo científico publicado en 2014

Anti-VDRL antibodies by ELISA in cerebrospinal fluid and its value in the differential diagnosis of abnormalities of the cerebrospinal fluid.

artículo científico publicado en 1992

Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.

artículo científico publicado en 2014

Antibodies against endothelial cells in patients with multiple sclerosis

artículo científico publicado en 1996

Antibodies against gangliosides in patients with SLE and neurological manifestations

artículo científico publicado el 1 de octubre de 1992

Anticardiolipin antibodies and migraine-related strokes

artículo científico publicado en 1988

Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis

artículo científico publicado en 2001

Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.

artículo científico publicado en 2006

Anticuerpos neutralizantes en pacientes con esclerosis múltiple tratados con interferón beta-1b

artículo científico publicado en 2000

Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome ⬇️

artículo científico publicado el 1 de enero de 1991

Antimyelin antibodies with no progression to multiple sclerosis.

artículo científico publicado en 2007

Antiviral immune response in patients with multiple sclerosis and healthy siblings

scientific article published on 01 March 2010

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

artículo científico publicado en 2010

Assessing response to interferon-β in a multicenter dataset of patients with MS.

artículo científico publicado en 2016

Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis

artículo científico publicado en 2014

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

artículo científico publicado en 2002

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

artículo científico publicado en 2014

Association Cluster Detector: a tool for heuristic detection of significance clusters in whole-genome scans.

artículo científico publicado en 2005

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

scientific article published on 10 February 2020

Asterixis associated with anatomic cerebral lesions: a study of 45 cases

artículo científico publicado en 1995

Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

artículo científico publicado en 2013

B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.

artículo científico publicado en 2010

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

artículo científico publicado en 2006

Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta

artículo científico publicado en 2013

Behçet's syndrome: intracranial hypertension without cerebral venous thrombosis

artículo científico publicado el 30 de enero de 1988

Bilateral third nerve palsy with pupil involvement as the first manifestation of multiple sclerosis

artículo científico publicado en 2011

Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.

artículo científico publicado en 2010

Biomarkers in multiple sclerosis

artículo científico publicado en 2013

Biomarkers in multiple sclerosis: an update for 2014

artículo científico publicado en 2014

Biosensors to monitor MS activity

artículo científico publicado en 2020

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

artículo científico publicado en 2017

Body fluid biomarkers in multiple sclerosis

artículo científico publicado en 2014

Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation

artículo científico publicado en 2017

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

artículo científico publicado en 2016

Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.

artículo científico publicado en 2017

Brain atrophy and lesion load predict long term disability in multiple sclerosis

artículo científico publicado en 2013

Brain atrophy in natalizumab-treated patients: A 3-year follow-up

artículo científico publicado en 2014

Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome

artículo científico publicado en 2019

Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.

artículo científico publicado en 2015

CD4(+)CD45RO(+)CD49d(high) cells are involved in the pathogenesis of relapsing-remitting multiple sclerosis

artículo científico publicado en 2000

CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases

scientific article published on 17 December 2019

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

artículo científico publicado en 2004

CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: No.

artículo científico publicado en 2013

Can the Expanded Disability Status Scale be assessed by telephone?

artículo científico publicado en 2003

Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta?

artículo científico publicado en 2000

Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis

artículo científico publicado en 2015

Cellular immune responses in multiple sclerosis patients treated with interferon-beta

artículo científico publicado en 2013

Central diabetes insipidus: a complication of herpes simplex encephalitis

artículo científico publicado en 1996

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

artículo científico publicado en 2010

Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis

artículo científico publicado en 2018

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.

artículo científico publicado en 2017

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

article

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

scientific article published on 21 October 2008

Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis.

artículo científico publicado en 2016

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

artículo científico publicado en 2011

Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.

artículo científico publicado en 1998

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients

scientific article published on 26 October 2018

Cladribine tablets added to IFN-β in active relapsing MS: The ONWARD study

artículo científico publicado en 2018

Classic Block Design "Pseudo"-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis

artículo científico publicado en 2018

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

artículo científico publicado en 2017

Clinical characteristics of responders to interferon therapy for relapsing MS

artículo científico publicado en 2004

Clinical impact of early brain atrophy in clinically isolated syndromes

artículo científico publicado en 2013

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

artículo científico publicado en 2004

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

artículo científico publicado en 2016

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

artículo científico publicado en 2014

Clinically definite multiple sclerosis after radiological Schilder-like onset

scientific article published on 01 July 2003

Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.

artículo científico publicado en 2005

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

artículo científico publicado en 2005

Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS

artículo científico publicado en 2019

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

artículo científico publicado en 2020

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

artículo científico publicado en 1999

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain

artículo científico publicado en 2018

Cognitive reserve in multiple sclerosis: Protective effects of education.

artículo científico publicado en 2015

Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.

artículo científico publicado en 2017

Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al

scientific article published on 27 January 2014

Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody

scientific article published on 06 February 2015

Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'.

artículo científico publicado en 2013

Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.

artículo científico publicado en 2015

Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis.

artículo científico publicado en 2016

Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.

artículo científico publicado en 2016

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

artículo científico publicado en 2010

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

artículo científico publicado en 2016

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

artículo científico publicado en 2015

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

artículo científico publicado en 2003

Conversión a esclerosis múltiple clínicamente definida tras un síndrome medular aislado: valor de la resonancia magnética craneal y medular

artículo científico publicado en 2001

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

artículo científico publicado en 2017

Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study

artículo científico publicado en 2019

Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

artículo científico publicado en 2016

Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial.

artículo científico publicado en 2004

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

artículo científico publicado en 2019

Cumulative Dose of Macrocyclic Gadolinium-Based Contrast Agent Improves Detection of Enhancing Lesions in Patients with Multiple Sclerosis.

artículo científico publicado en 2017

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

artículo científico publicado en 2016

DNA Vaccination Techniques.

artículo científico publicado en 2016

DNA-based vaccines for multiple sclerosis: current status and future directions.

artículo científico publicado en 2010

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

artículo científico publicado en 2014

Decreased MMP-9 production in primary progressive multiple sclerosis patients

article

Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.

artículo científico publicado en 2016

Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis

artículo científico publicado en 2006

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

artículo científico publicado en 2015

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

article

Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

artículo científico publicado en 2018

Diagnosis and treatment of MS in Latin America. MS Forum Interactive Symposium at the LACTRIMS Congress, 27 August 2004, Iguazu Falls, Brazil

scientific article published on 01 December 2004

Diagnosis and trials of clinically isolated syndrome

scientific article published on 02 September 2014

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

artículo científico publicado en 2017

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria

artículo científico publicado en 2017

Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes

scholarly article by Raquel Mitjana et al published 27 February 2014 in Multiple Sclerosis Journal

Differential diagnosis of suspected multiple sclerosis: a consensus approach

artículo científico publicado en 2008

Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design

artículo científico publicado en 2015

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

artículo científico publicado en 2019

Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS

artículo científico publicado en 2009

Disability progression markers over 6-12 years in interferon-β-treated multiple sclerosis patients.

artículo científico publicado en 2017

Disease-modifying therapy in multiple sclerosis: Two guidelines (almost) passing in the night

artículo científico publicado en 2018

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

artículo científico publicado en 2009

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

artículo científico

Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?

article

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

article

EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy

scientific article published on 21 October 2011

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

artículo científico publicado en 2018

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

artículo científico publicado en 2018

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.

artículo científico publicado en 2013

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.

artículo científico publicado en 2013

Early predictors of multiple sclerosis after a typical clinically isolated syndrome.

artículo científico

Early treatment: PreCISe-ly what the patient needs.

artículo científico publicado en 2009

Early vocal cord paralysis in olivopontocerebellar atrophy

artículo científico publicado en 1996

Efecto a largo plazo de los anticuerpos neutralizantes de interferón beta-1 b en pacientes con esclerosis múltiple

artículo científico publicado en 2005

Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis

artículo científico publicado en 2017

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2009

Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC

scientific article published on 01 October 2019

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.

artículo científico publicado en 2015

Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome

artículo científico publicado en 2012

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study

scientific article published on 25 July 2018

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

artículo científico publicado en 2010

Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b.

artículo científico publicado en 1999

Empty sella syndrome and pituitary apoplexy

artículo científico publicado en 1988

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

artículo científico publicado en 2017

Erratum to: Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis

scholarly article published in Journal of Neurology

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

article

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis

scientific article published on 19 August 2019

Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis

artículo científico publicado en 2008

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

artículo científico publicado en 2015

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

artículo científico publicado en 2015

Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images

artículo científico publicado en 1999

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course

artículo científico publicado en 2018

Expression of Bone Morphogenetic Proteins in Multiple Sclerosis Lesions

artículo científico publicado en 2018

Expression of chemokine receptors in the different clinical forms of multiple sclerosis

artículo científico publicado en 2002

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.

artículo científico publicado en 2015

FTY720 (fingolimod) for relapsing multiple sclerosis.

artículo científico publicado en 2008

Facial nerve palsy due to angioedema in systemic lupus erythematosus

artículo científico publicado en 1991

Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.

artículo científico publicado en 2005

Fatigue in multiple sclerosis persists over time

article

Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone

article

Fingolimod for relapsing multiple sclerosis: an update.

artículo científico publicado en 2010

Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.

artículo científico publicado en 2012

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.

artículo científico publicado en 2013

Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension

artículo científico publicado en 2020

FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

scientific article published on 16 February 2014

Frequency of Multiple Sclerosis in Menorca, Balearic Islands, Spain

article

Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice

artículo científico publicado en 1998

Generation of six multiple sclerosis patient-derived induced pluripotent stem cell lines

artículo científico publicado en 2017

Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.

artículo científico publicado en 2004

Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis

artículo científico publicado en 2005

Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis

artículo científico publicado en 2009

Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis

artículo científico publicado en 2010

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

artículo científico publicado en 2011

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

artículo científico publicado en 2015

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

artículo científico publicado en 2008

Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

artículo científico publicado en 2009

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.

artículo científico publicado en 2013

Genome-wide significant association with seven novel multiple sclerosis risk loci

artículo científico publicado en 2015

Grey matter atrophy is associated with disability increase in natalizumab-treated patients.

artículo científico publicado en 2016

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

scientific article published on 14 March 2017

HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis

artículo científico publicado en 2014

HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis.

artículo científico publicado en 2009

Head-to-head drug comparisons in multiple sclerosis: Urgent action needed

artículo científico publicado en 2019

Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report

artículo científico publicado en 2020

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

artículo científico publicado en 2006

High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis

artículo científico publicado en 1996

Hsp70 regulates immune response in experimental autoimmune encephalomyelitis

artículo científico publicado en 2014

IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis

scientific article published on 01 September 2011

Iatrogenic fulminant beriberi

scientific article published on 01 July 1995

Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS

scientific article published on 01 April 2000

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

artículo científico publicado en 2012

Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms

artículo científico publicado en 2008

Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.

artículo científico publicado en 2014

Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules

scientific article published on 01 December 1999

Immunotherapy for neurological diseases

scientific article published on 04 June 2008

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition

artículo científico publicado en 2008

Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.

artículo científico publicado en 2011

Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields

artículo científico publicado en 2016

Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

artículo científico publicado en 2012

Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.

artículo científico publicado en 2003

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.

artículo científico publicado en 2008

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.

artículo científico publicado en 2015

Information searching for multiple sclerosis

artículo científico publicado en 1998

Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis

article

Innovation in resident education - Description of the Neurology International Residents Videoconference and Exchange (NIRVE) program

artículo científico publicado en 2020

Interferon beta in relapsing–remitting multiple sclerosis

artículo científico publicado en 2005

Interferon beta in secondary progressive multiple sclerosis : daily clinical practice.

artículo científico publicado en 2007

Interferon beta-1b treatment in patients with relapsing--remitting multiple sclerosis under a standardized protocol in Spain

artículo científico publicado en 2000

Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

artículo científico publicado en 2011

Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

artículo científico publicado en 2011

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome.

artículo científico publicado en 2011

Interferon-beta 1b in the treatment of multiple sclerosis.

artículo científico publicado en 2005

Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.

artículo científico publicado en 2014

Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis

artículo científico publicado en 2002

Intracranial involvement in neurosarcoidosis: a report of 4 cases as initial manifestation of the disease

artículo científico publicado en 1999

Introduction

artículo científico publicado en 2007

Is optic neuritis more benign than other first attacks in multiple sclerosis?

artículo científico publicado en 2005

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.

artículo científico publicado en 2001

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis

artículo científico publicado en 2000

Jun expression is found in neurons located in the vicinity of subacute plaques in patients with multiple sclerosis.

artículo científico publicado en 1996

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

artículo científico publicado en 2015

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

scientific article published on 08 May 2019

Lack of association between hepatitis G virus and multiple sclerosis

artículo científico publicado en 1998

Lambert-Eaton Myasthenic syndrome associated with sarcoidosis

scientific article published on 20 April 2005

Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis

scientific article published on 21 January 2008

Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.

artículo científico publicado en 2016

Lesion topographies in multiple sclerosis diagnosis: A reappraisal

artículo científico publicado en 2017

Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis

scientific article published on 16 April 2014

Lhermitte's sign in pseudotumour cerebri

artículo científico publicado en 1995

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

artículo científico publicado en 2015

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

artículo científico publicado en 2015

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2020

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.

artículo científico publicado en 2013

Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis

artículo científico publicado en 2015

Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study

scientific article published on 25 May 2020

Low frequency and rare coding variation contributes to multiple sclerosis risk

Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS.

artículo científico publicado en 1998

Lower motor neuron disease in a HIV-2 infected woman

article

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

artículo científico publicado en 2020

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

artículo científico publicado en 2013

MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique?

artículo científico publicado en 2011

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

artículo científico publicado en 2006

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain

artículo científico publicado en 2007

MRI criteria for MS in patients with clinically isolated syndromes

artículo científico publicado en 2010

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.

artículo científico publicado en 2006

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

artículo científico publicado en 2007

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

artículo científico publicado en 2016

MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.

artículo científico publicado en 2009

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

artículo científico

MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes.

artículo científico publicado en 2015

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry

artículo científico publicado en 2019

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

artículo científico publicado en 2013

Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.

artículo científico publicado en 2017

Measurement of Cortical Thickness and Volume of Subcortical Structures in Multiple Sclerosis: Agreement between 2D Spin-Echo and 3D MPRAGE T1-Weighted Images

artículo científico publicado en 2016

Measures in the first year of therapy predict the response to interferon β in MS

article

Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

scientific article published on 01 March 2019

Metabolomic signatures associated with disease severity in multiple sclerosis

artículo científico publicado en 2017

Metallothionein expression in the central nervous system of multiple sclerosis patients

artículo científico publicado en 2003

Mitoxantrone

artículo científico publicado en 2003

Modafinil and fatigue in multiple sclerosis

artículo científico publicado en 2004

Modelling multiple sclerosis using induced pluripotent stem cells

artículo científico publicado en 2020

Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.

artículo científico publicado en 2015

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

artículo científico publicado en 2014

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica

artículo científico publicado en 2016

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

artículo científico publicado en 2005

Multiple Sclerosis: Epidemiologic, Clinical, and Therapeutic Aspects.

artículo científico publicado en 2017

Multiple sclerosis and nutrition: back to the future?

scientific article published on 31 July 2020

Multiple sclerosis in 2013: novel triggers, treatment targets and brain atrophy measures

artículo científico publicado en 2014

Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system.

artículo científico publicado en 2017

Multiple sclerosis: clinical aspects

artículo científico publicado en 2018

Multiple sclerosis: current treatment algorithms.

artículo científico publicado en 2011

Multiple sclerosis: more pieces of the immunological puzzle.

artículo científico publicado en 2012

Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

scientific article published on 24 August 2018

Myeloid-derived suppressor cells are generated during retroviral transduction of murine bone marrow.

artículo científico publicado en 2012

Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis

artículo científico publicado en 2016

Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis

artículo científico publicado en 2003

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

scientific article published on 13 April 2020

NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.

artículo científico publicado en 2015

NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

artículo científico publicado en 2017

NMO spectrum disorders: how wide is the spectrum?

artículo científico publicado en 2014

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

artículo científico publicado en 2012

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study

artículo científico publicado en 2012

Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.

artículo científico publicado en 2014

Natalizumab: risk stratification of individual patients with multiple sclerosis

artículo científico publicado en 2014

Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis

artículo científico publicado en 2018

Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis

article

Nerve conduction velocity is regulated by the inositol polyphosphate-4-phosphatase II gene.

artículo científico publicado en 2014

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome

artículo científico publicado en 2018

Neurofilament light chain level is a weak risk factor for the development of MS.

artículo científico publicado en 2016

Neurokinin concentrations in cerebrospinal fluid. A preliminary study in Parkinson's disease

artículo científico publicado el 1 de mayo de 1992

Neurologic manifestations of Mycoplasma pneumoniae

artículo científico publicado el 1 de febrero de 1988

Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.

artículo científico publicado en 2006

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus

artículo científico publicado en 2016

New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword

artículo científico publicado en 2011

No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis

scientific article published on 16 April 2014

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

artículo científico publicado en 2015

Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.

artículo científico publicado en 2016

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

artículo científico publicado en 2018

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

artículo científico publicado en 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

artículo científico publicado en 2016

Ocrelizumab: a new milestone in multiple sclerosis therapy.

artículo científico publicado en 2018

Ofatumumab versus Teriflunomide in Multiple Sclerosis

artículo científico publicado en 2020

Olfactory dysfunction in multiple sclerosis: association with secondary progression.

artículo científico publicado en 2011

Oligoclonal bands do not represent dissemination in time in the 2017 revisions to the McDonald criteria

scientific article published on 16 May 2019

Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.

artículo científico publicado en 2015

Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.

artículo científico publicado en 2011

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

artículo científico publicado en 2010

Orchestrating innate immune responses in multiple sclerosis: molecular players.

artículo científico publicado en 2010

Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education

artículo científico publicado en 2017

Overview of European pilot study of interferon beta-Ib in primary progressive multiple sclerosis.

artículo científico publicado en 2004

PML risk stratification using anti-JCV antibody index and L-selectin.

artículo científico publicado en 2015

Parkinsonian hemi-syndrome as the initial manifestation of supratentorial cystic hemangioblastoma in a patient with Von Hippel-Lindau disease

artículo científico publicado en 1998

Paroxysmal nocturnal hemoglobinuria and priapism

artículo científico publicado en 1986

Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats

artículo científico publicado en 2000

Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta

scientific article published on 25 September 2015

Peripheral neuropathy in association with insulinoma: clinical features and neuropathology of a new case

artículo científico publicado en 1994

Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.

artículo científico publicado en 2003

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.

artículo científico publicado en 2015

Placebo-controlled trial of oral laquinimod for multiple sclerosis

artículo científico publicado en 2012

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

artículo científico

Plasma chitotriosidase activity in multiple sclerosis.

artículo científico publicado en 2009

Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.

artículo científico publicado en 2009

Plasma levels of 15d-PGJ2are not altered in multiple sclerosis

artículo científico publicado en 2009

Plasma osteopontin levels in multiple sclerosis.

artículo científico publicado en 2005

Polyglandular autoimmune syndrome type II and multiple sclerosis

artículo científico publicado en 2001

Polymyositis as the first manifestation of acquired immunodeficiency syndrome

artículo científico publicado el 1 de marzo de 1991

Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort.

artículo científico publicado en 2007

Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.

artículo científico publicado en 2013

Power estimation for non-standardized multisite studies

artículo científico publicado en 2016

Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.

artículo científico publicado en 2016

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

scientific article published on 01 June 2008

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study

artículo científico publicado en 2017

Predictive value of early brain atrophy on response in patients treated with interferon β

artículo científico publicado en 2015

Pregnancy, sex and hormonal factors in multiple sclerosis.

artículo científico publicado en 2014

Primary progressive multiple sclerosis

artículo científico publicado en 2001

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

artículo científico publicado en 2009

Primary progressive multiple sclerosis.

artículo científico publicado en 2005

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

artículo científico publicado en 2010

Progressive MS trials: Lessons learned

artículo científico publicado en 2017

Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis

artículo científico publicado en 2015

Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis

artículo científico publicado en 2000

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.

artículo científico publicado en 2015

Quantitative spinal cord MRI in radiologically isolated syndrome

artículo científico publicado en 2018

Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTORE

scientific article published on 09 November 2014

Radiologically isolated syndrome: 5-year risk for an initial clinical event

artículo científico publicado en 2014

Ratio of T1-Weighted to T2-Weighted Signal Intensity as a Measure of Tissue Integrity: Comparison with Magnetization Transfer Ratio in Patients with Multiple Sclerosis

scientific article published on 05 March 2020

Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.

artículo científico publicado en 2008

Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis

artículo científico publicado en 2019

Recurrent Guillain-Barré syndrome and CNS demyelination

artículo científico publicado en 1997

Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.

artículo científico publicado en 2015

Regulatory lymphocytes are key factors in MHC-independent resistance to EAE

artículo científico publicado en 2014

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study

artículo científico publicado en 2008

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

article

Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study

artículo científico publicado en 2010

Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.

artículo científico publicado en 2010

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes

article

Reproducibility of fMRI in the clinical setting: implications for trial designs

artículo científico publicado en 2008

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

artículo científico publicado en 2016

Responsiveness and predictive value of EDSS and MSFC in primary progressive MS

artículo científico publicado en 2008

Respuesta

artículo científico publicado en 2013

Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond

artículo científico publicado en 2018

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study

scientific article published on 01 July 2019

Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease.

artículo científico publicado en 2002

Review of methodological issues of clinical trials in multiple sclerosis.

artículo científico

Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).

artículo científico publicado en 2015

Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting

artículo científico publicado en 2016

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

artículo científico

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.

artículo científico publicado en 2009

Risk acceptance in multiple sclerosis patients on natalizumab treatment.

artículo científico publicado en 2013

Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis

artículo científico publicado en 2018

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis

artículo científico publicado en 2015

Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.

artículo científico publicado en 2004

Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.

artículo científico publicado en 2013

SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis

scientific article published on 29 August 2012

SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts

artículo científico publicado en 2017

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

artículo científico

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.

artículo científico publicado en 2016

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

scientific article published on 03 September 2019

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

scientific article published on 03 September 2019

Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis

scientific article published on 20 November 2018

Scoring treatment response in patients with relapsing multiple sclerosis.

artículo científico publicado en 2012

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

artículo científico publicado en 2011

Secondary progression is not the only explanation.

artículo científico publicado en 2014

Secondary progressive NMO, or concomitant NMO and a primary neurodegenerative disorder?

scientific article published on 10 September 2015

Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis

artículo científico publicado en 2016

Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis

artículo científico publicado en 2013

Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report.

artículo científico publicado en 2002

Serial gadolinium-enhanced MRI in acute attack of multiple sclerosis treated with plasma exchange.

artículo científico publicado en 2003

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients

scientific article published on 01 July 2003

Serum Homocysteine Levels in Multiple Sclerosis

scientific article published on 01 December 1994

Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report.

artículo científico publicado en 2018

Short-term adaptation to a simple motor task: a physiological process preserved in multiple sclerosis.

artículo científico publicado en 2008

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

artículo científico publicado en 2015

Significant clinical worsening after natalizumab withdrawal: Predictive factors

article

Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis

article

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

artículo científico publicado en 2018

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

artículo científico publicado en 2013

Skin hyper-reactivity in patients with benign intracranial hypertension as an early manifestation of Behçet's disease

scientific article published on 01 February 1995

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

artículo científico publicado en 2017

Spanish consensus on the use of natalizumab (Tysabri®)-2013.

artículo científico publicado en 2013

Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse

scientific article published on 01 February 2002

Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes

artículo científico publicado en 2004

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

artículo científico publicado en 2017

Stem cell-based treatment of neurologic diseases

artículo científico publicado en 2012

Subcutaneous alemtuzumab for multiple sclerosis

artículo científico publicado en 2012

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

artículo científico publicado en 2015

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

artículo científico publicado en 2010

THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.

artículo científico publicado en 2011

TNF-376A marks susceptibility to MS in the Spanish population: A replication study.

artículo científico publicado en 2004

TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.

artículo científico publicado en 2013

Targeting dendritic cells to treat multiple sclerosis.

artículo científico publicado en 2010

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis

artículo científico publicado en 2020

The Central Vein Sign in Radiologically Isolated Syndrome

scientific article published on 18 April 2019

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β

article

The Multiple Sclerosis Care Unit

artículo científico publicado en 2018

The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility

scholarly article published 13 July 2017

The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

artículo científico publicado en 2020

The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history

artículo científico publicado en 2020

The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis

artículo científico publicado en 2010

The basal ganglia: a substrate for fatigue in multiple sclerosis.

artículo científico publicado en 2007

The immune response against herpesvirus is more prominent in the early stages of MS.

artículo científico publicado en 2003

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

artículo científico publicado en 2019

The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - No.

artículo científico publicado en 2017

The pros and cons of early treatment of relapsing forms of multiple sclerosis.

artículo científico publicado en 2004

The proteasome is a major autoantigen in multiple sclerosis.

artículo científico publicado en 2002

The role of B cells in Multiple Sclerosis and related disorders

artículo científico publicado en 2020

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

artículo científico publicado en 2018

The search for responsive clinical endpoints in primary progressive multiple sclerosis

scientific article published on 21 April 2009

The value of animal models for drug development in multiple sclerosis.

artículo científico publicado en 2006

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

artículo científico publicado en 2018

Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists

article

Therapeutic Inertia in the New Landscape of Multiple Sclerosis Care.

artículo científico publicado en 2018

Therapy adherence to immunomodulator treatment in patients with multiple sclerosis

artículo científico publicado en 2013

Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis

artículo científico publicado en 2005

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

artículo científico publicado en 2019

Transcription-based prediction of response to IFNbeta using supervised computational methods

artículo científico publicado en 2005

Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy.

artículo científico publicado en 2015

Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations

scientific article published on 06 April 2020

Treatment decisions in multiple sclerosis - insights from real-world observational studies.

artículo científico publicado en 2017

Treatment of cognitive impairment in multiple sclerosis: position paper

artículo científico publicado en 2012

Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial

artículo científico publicado en 1995

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.

artículo científico publicado en 2012

Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice.

artículo científico publicado en 2001

Treatment with interferon-β does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients

artículo científico publicado en 2012

Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

artículo científico publicado en 2002

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge

artículo científico publicado en 2018

Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients.

artículo científico publicado en 2013

Usability of an Educational Intervention to Overcome Therapeutic Inertia in Multiple Sclerosis Care.

artículo científico publicado en 2018

Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.

artículo científico publicado en 2011

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis

artículo científico publicado en 2014

Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis

scientific article published on 21 May 2020

Value of NMO-IgG determination at the time of presentation as CIS

artículo científico publicado en 2012

Value of immunologic testing in stroke patients. A prospective multicenter study

artículo científico publicado en 1994

Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients

artículo científico publicado en 2006

Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab.

artículo científico publicado en 2017

Very early scans for demonstrating dissemination in time in multiple sclerosis

artículo científico publicado en 2008

Vitamin D as an early predictor of multiple sclerosis activity and progression

artículo científico publicado en 2014

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT

scientific article published on 16 April 2020

Will Rogers phenomenon in multiple sclerosis.

artículo científico publicado en 2008

Workshop on primary progressive multiple sclerosis: meeting summary.

artículo científico publicado en 2002

[Acute disseminated encephalomyelitis: study of factors involved in a possible development towards multiple sclerosis]

artículo científico publicado en 2008

[Antiendothelial cell antibodies]

scientific article published on 01 November 1990

[Cerebral gliomatosis]

scientific article published on 01 March 2008

[Clinical usefulness of oligoclonal bands]

article

[Cognitive impairment caused by valproate]

scientific article published on 01 December 2000

[Consensus document on spasticity in patients with multiple sclerosis. Grupo de Enfermedades Desmielinizantes de la Sociedad Española de Neurología]

scientific article published on 01 October 2013

[Current description of multiple sclerosis]

artículo científico publicado en 2014

[Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature].

artículo científico publicado en 2010

[Descriptive study of first visits in a multiple sclerosis specialised unit]

artículo científico publicado en 2002

[Diffuse astrocytoma presenting as an optic-spinal syndrome]

artículo científico publicado en 2009

[Electrocution: neurological complications]

scientific article published on 01 March 1999

[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]

artículo científico publicado en 2012

[Guillain-Barré syndrome and gangliosides]

scientific article published on 01 July 1995

[Headache in an epidemic of multiple sclerosis: should other causes be excluded?]

artículo científico publicado en 1996

[High cerebrospinal fluid protein levels and intracranial pressure limit values in a patient with benign sexual headache]

scientific article published on 01 August 2000

[Homonymous quadrantanopia as a presentation form of multiple sclerosis]

artículo científico publicado en 1999

[Hypophyseal reapoplexy: description of a case]

artículo científico publicado en 1993

[Interobserver variability in the evaluation of functional systems and Kurzke expanded disability status scale in a multiple sclerosis patient]

artículo científico publicado en 1996

[Lupus anticoagulant and cerebrovascular stroke]

artículo científico publicado en 1988

[Monoclonal antibodies in [corrected] development in [corrected] multiple sclerosis]

scientific article published on 08 April 2011

[Natalizumab in multiple sclerosis]

artículo científico publicado en 2009

[Natural interferon-beta in the treatment of relapsing-remitting multiple sclerosis: a multicenter, randomized, MRI-based, phase II clinical trial]

scientific article published on 01 December 1999

[Neuro-Behçet]

scientific article published on 01 August 1994

[Neurorehabilitation in multiple sclerosis.]

artículo científico publicado en 2005

[Optic neuritis and multiple sclerosis]

artículo científico publicado en 1998

[Optic neuritis, brain stem syndromes and myelitis: rapid conversion to multiple sclerosis]

artículo científico publicado en 1999

[Pachymeningitis as a first manifestation of an overlap vasculitic syndrome]

artículo científico publicado en 2005

[Primary progressive multiple sclerosis]

artículo científico publicado en 2002

[Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b]

scientific article published on 01 November 1998

[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis]

[Recommendations for the clinical use of motor evoked potentials in multiple sclerosis].

artículo científico publicado en 2012

[Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score]

[Retinal periphlebitis in multiple sclerosis. A prospective study]

artículo científico publicado en 1993

[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)]

artículo científico publicado en 2015

[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)]

artículo científico publicado en 2011

[Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)]

artículo científico publicado en 2011

[Solitary cerebellar metastases: a clinical neuro-radiological study]

artículo científico publicado en 1988

[Spanish Neurology Society consensus document on the use of drugs in multiple sclerosis: escalating therapy]

scientific article published on 01 July 2010

[Spanish adaptation of the disease-specific questionnaire MSQOL-54 in multiple sclerosis patients]

artículo científico publicado en 2006

[Spanish multi-centre observational study of the first attacks suggestive of multiple sclerosis: the PREM cohort]

artículo científico publicado en 2011

[Syphilitic meningoradiculitis in a patient with HIV]

scientific article published on 01 June 1994

[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study]

scientific article published on 01 September 1997

[The relation between Sheehan's syndrome and the empty sella turcica]

scientific article published on 01 March 1991

[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)]

[Usefulness of serial cranial MR in isolated myelitis for the diagnosis of multiple sclerosis]

scientific article published on 01 September 1995

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda